期刊文献+

VPA和As2O3对Molt-4细胞的协同作用及可能机制 被引量:2

Synergistic Effects of VPA and As_2O_3 on Molt-4 Cells in Vitro and Its Possible Mechanisms
在线阅读 下载PDF
导出
摘要 本研究探讨丙戊酸钠(sodium valproate,VPA)单药或与亚砷酸(arsenie trioxide,As2O3)联用对人急性T细胞白血病细胞株Molt-4增殖活力的抑制、去甲基化作用及其可能机制。用MTT法检测药物对细胞增殖的抑制作用,利用金氏公式观察两药联用体外抗癌的协同作用。采用半巢式甲基化特异PCR(hnMS-PCR)检测p15INK4B基因甲基化,RT-PCR方法检测p15基因、DNA甲基转移酶DNMT-1、DNMT3A、DNMT3B的表达。结果表明:VPA和As2O3均可明显抑制细胞增殖,二者联用在体外有相加作用(Q值均大于0.85),在5mmol/L VPA与10μmol/L As2O3联用时抑制率达(70.31±2.54)%。Molt-4细胞p15基因因高甲基化而失表达,经VPA和As2O3联合作用后p15基因甲基化程度明显下降,p15基因表达增强,两药联用时DNMT-1、DNMT-3A、DNMT3BmRNA的表达都有下降。结论:VPA可能通过抑制DNA甲基转移酶DNMT-1和(或)DNMT3B使p15INK4B基因去甲基化,使p15基因表达上调,恢复其活性。VPA和As2O3均可明显抑制Mol-4细胞增殖,两药合用有协同相加作用,可减少砷剂的副作用。 This study was purposed to investigate the synergistic effects of sodium valproate (VPA) and As2O3 on the proliferation of Molt-4 cells in vitro and its possible mechanisms. Cell viability and growth curve were assessed by the MTT assay. The synergistic activity in combination of 2 drugs was determined by the Q format. The expression levels of p15, DNA methyltransferase 1 ( DNMT-1 ), DNMT3A and DNMT 3B mRNA were detected by RT-PCR and the methylation level was detected by hn-MSPCR. The results indicated that the VPA and As2O3 both inhibited proliferation of Molt-4 cells. The combination of two drugs showed an additive effect ( values of Q were ≥0.85 ). The inhibitory rate in combination of 5 mmol/L of VPA with 10 μmol/L of As2O3 was (70.31 ±2.54) %. The p15 gene in Molt-4 cell line failed to express due to its hypermethylation. The level of p15 gene mRNA expression increased significantly after exposure to VPA in combination with As2O3 for 48h. As compared with control group, the expression of DNMT-1 was down-regulated in a dose-dependent manner, whereas DNMT3A had no significant differences from the control. The level of expression of DNMT3B seemed to decrease at 10 mmol/L concentration. There were significant differences between the combination of the two drugs and the control group. The gray value of methylated bands decreased after the treatment of VPA alone and in combination with As2O3 in a dose-dependent manner. It is concluded that VPA induces demethylation of p15 INK4B gene by inhibiting the DNMT-1 and DNMT3B gene activities, which upregulates the p15 gene, recovers its activity. The combination of VPA with As2O3 has the synergetic additive effect on the inhibition of cell viabilitiy, so that VPA can reduce the side effect of As2 O3 on liver function, which would be verified in the clinical practice.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第6期1288-1292,共5页 Journal of Experimental Hematology
基金 漳州市2004年科技计划项目(编号Z04053) 福建省自然基金立项(编号C0540014)
关键词 丙戊酸钠 AS2O3 MOLT-4细胞 甲基转移酶 P15基因甲基化 sodium valproate arsenic trioxide Molt-4 cell methytransferase p15 methylation
作者简介 通讯作者:叶宝国,教授,主任医师,硕士生导师.电话:(0596)2082022.E-mail:yebaoguo126@yahoo.cn
  • 相关文献

参考文献9

二级参考文献45

共引文献168

同被引文献16

  • 1姜凤云,郝长来,王建祥.组蛋白脱乙酰化酶抑制剂在治疗白血病中的研究进展[J].白血病.淋巴瘤,2004,13(5):316-318. 被引量:2
  • 2周华蓉,沈建箴,付海英,叶宝国,范丽萍,林福安.巢式MSP法检测恶性血液病细胞株p16基因启动子甲基化状态的研究[J].中国实验血液学杂志,2006,14(2):375-378. 被引量:13
  • 3Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histone deacetylase is a target of valproic acid mediated cellular diferentiation. Cancer Res,2004 ;64 ( 3 ) : 1079 - 1086.
  • 4Huang X, Guo B. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res,2006 ;66 ( 18 ) :9245 - 9251.
  • 5Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases: a common molecular target for diferentiation treatment of acute myeloid leukemias. Oncogene, 2001 ; 20 ( 24 ) : 3110 - 3115.
  • 6Lin YY, Qi Y, Lu JY, et al. A comprehensive synthetic genetic interaction network governing yeast histone acetylation and deacetylation. Genes Dev, 2008 ;22 ( 15 ) :2062 - 2074.
  • 7Weidle UH, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res, 2000 ; 20 (3A) : 1471 - 1485.
  • 8Bradbury CA, Khanim FL, Hayden R, et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia, 2005 ;19(10) : 1751 - 1759.
  • 9Nadia G, Oxana M, Tsygankova et al. Histone deacetylase is a target of valproic acid - mediated cellular differentiation. Cancer Res, 2004 ;64 : 1079 - 1086.
  • 10Gurvich N,Tsygankova OM,Meinkoth JL,et al.Histone deacelylase is atarget of valproic acid mediated cellular diferentiation.Cancer Res,2004,64:1079-1086.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部